Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß

por Hurtado-Guerrero, Isaac, Pinto-Medel, Maria Jesús, Urbaneja, Patricia, Rodriguez- Bada, Jose Luis, León, Antonio, Guerrero, Miguel, Fernández, Óscar, Leyva, Laura, Oliver-Martos, Begoña
Publicado 2017

Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway

por Hurtado-Guerrero, Isaac, Pinto-Medel, Maria Jesus, Urbaneja, Patricia, Rodriguez-Bada, Jose Luis, Ortega-Pinazo, Jesús, Serrano, Pedro, Fernández, Óscar, Leyva, Laura, Oliver-Martos, Begoña
Publicado 2017

Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations

por Ciano-Petersen, Nicolás Lundahl, Aliaga-Gaspar, Pablo, Hurtado-Guerrero, Isaac, Reyes, Virginia, Rodriguez-Bada, José Luis, Rodriguez-Traver, Eva, Brichette-Mieg, Isabel, Leyva Fernández, Laura, Serrano-Castro, Pedro, Alonso, Ana, Oliver-Martos, Begoña
Publicado 2023

Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment

por Aliaga-Gaspar, Pablo, Hurtado-Guerrero, Isaac, Ciano-Petersen, Nicolas Lundahl, Urbaneja, Patricia, Brichette-Mieg, Isabel, Reyes, Virginia, Rodriguez-Bada, Jose Luis, Alvarez-Lafuente, Roberto, Arroyo, Rafael, Quintana, Ester, Ramió-Torrentà, Lluis, Alonso, Ana, Leyva, Laura, Fernández, Oscar, Oliver-Martos, Begoña
Publicado 2021